Education
About Us
Working with TipRanks
Follow Us
Physitrack Limited (SE:PTRK)
:PTRK
PTRK Stock Chart & Stats
kr13.15
kr0.20(1.54%)
At close: 4:00 PM EST
kr13.15
kr0.20(1.54%)
Day’s Range― - ―
52-Week Rangekr8.52 - kr21.70
Previous CloseN/A
Volume8.48K
Average Volume (3M)49.62K
Market Cap
kr153.18M
Enterprise Valuekr18.51M
Total Cash (Recent Filing)kr603.34K
Total Debt (Recent Filing)kr4.04M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Feb 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding16,260,765
10 Day Avg. Volume41,844
30 Day Avg. Volume49,617
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.62
Price to Sales (P/S)0.73
P/FCF Ratio-32.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow ImprovementA 126% improvement in free cash flow over the trailing period indicates materially better cash generation and working-capital management. This durable cash uplift reduces dependence on external financing, supports reinvestment in product and sales, and lengthens runway over the next several quarters.
High Gross MarginA gross margin near 79% reflects the scalable economics of a software and content-led rehab platform. High incremental margins mean new subscription or licensing revenue converts strongly to gross profit, enabling potential long-term operating leverage if fixed costs are controlled.
Strong Cash ConversionAn operating cash flow to net income ratio of 0.84 shows reported results largely convert into cash, indicating revenue quality and disciplined cash collections. This durable cash conversion supports liquidity management and funds ongoing product development without immediate capital raises.
Bears Say
Declining RevenueNegative revenue growth near -8% signals shrinking recurring top line for a subscription business, implying customer churn, suppressed new-sales momentum, or pricing pressure. Without revenue stabilization, scalability and margin improvement will be hard to achieve over the medium term.
Persistent UnprofitabilityContinued negative net and EBIT margins indicate the business still operates below breakeven despite high gross margins. Structural cost issues in sales, R&D or G&A need resolving to translate strong unit economics into corporate profitability over the coming quarters.
Weak Return On EquityA negative return on equity shows the company is not generating adequate returns on shareholder capital. Over a multi-quarter horizon this constrains ability to attract new equity and highlights execution gaps in turning assets and investments into sustainable profits.
PTRK FAQ
What was Physitrack Limited’s price range in the past 12 months?
Physitrack Limited lowest stock price was kr8.52 and its highest was kr21.70 in the past 12 months.
What is Physitrack Limited’s market cap?
Physitrack Limited’s market cap is kr153.18M.
When is Physitrack Limited’s upcoming earnings report date?
Physitrack Limited’s upcoming earnings report date is Feb 27, 2026 which is in 9 days.
How were Physitrack Limited’s earnings last quarter?
Physitrack Limited released its earnings results on Oct 21, 2025. The company reported -kr0.106 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.106.
Is Physitrack Limited overvalued?
According to Wall Street analysts Physitrack Limited’s price is currently Overvalued.
Does Physitrack Limited pay dividends?
Physitrack Limited does not currently pay dividends.
What is Physitrack Limited’s EPS estimate?
Physitrack Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Physitrack Limited have?
Physitrack Limited has 16,260,765 shares outstanding.
What happened to Physitrack Limited’s price movement after its last earnings report?
Physitrack Limited reported an EPS of -kr0.106 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -17.067%.
Which hedge fund is a major shareholder of Physitrack Limited?
Currently, no hedge funds are holding shares in SE:PTRK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Physitrack Limited
Physitrack PLC, together with its subsidiaries, operates as a digital healthcare provider worldwide. It offers SaaS platform, a cloud-based software platform used by single practitioners and large healthcare organizations, which enables the digitalization of the patient journey, from initial contact to patient interactions and outcomes tracking. The company also delivers virtual care in three distinct but related patient and insurance plan member need areas, such as prevention and wellness care, acute and chronic care, and surgical care. It offers its virtual care solutions to healthcare companies, including private and public hospitals, clinics, and other business owners. The company was formerly known as Physitrack Limited and changed its name to Physitrack PLC in May 2021. Physitrack PLC was incorporated in 2012 and is based in London, the United Kingdom.
Technical Analysis
Aino Health AB
―
Isofol Medical AB
―
Q-linea AB
―
Kontigo Care AB
―
Active Biotech AB
―